Advances in immunotherapeutic strategies for colorectal cancer commentary on: tumoral immune cell exploitation in colorectal cancer metastases can be targeted effectively by anti-C...

por Deming, Dustin A.
Publicado 2016

Molecular Evolution of a Glioblastoma Controlled With Tumor Treating Fields and Concomitant Temozolomide

por Robins, H. Ian, Nguyen, HuyTram N., Field, Aaron, Howard, Steven, Salamat, Shahriar, Deming, Dustin A.
Publicado 2018

Inhibition of B-cell lymphoma 2 family proteins alters optical redox ratio, mitochondrial polarization, and cell energetics independent of cell state

por Gillette, Amani A., DeStefanis, Rebecca A., Pritzl, Stephanie L., Deming, Dustin A., Skala, Melissa C.
Publicado 2022

Case report: Radiographic complete response of radiation-induced glioblastoma to front-line radiotherapy: A report and molecular characterization of two unique cases

por Grogan, Patrick T., Helgager, Jeffrey J., Deming, Dustin A., Howard, Steven P., Jenkins, Robert B., Robins, H. Ian
Publicado 2023

Entrectinib demonstrates prolonged efficacy in an adult case of radiation-refractory NTRK fusion glioblastoma

por Grogan, Patrick T, Deming, Dustin A, Helgager, Jeffrey, Ruszkiewicz, Theresa, Baskaya, Mustafa K, Howard, Steven P, Robins, H Ian
Publicado 2022

The conserved protective cyclic AMP-phosphodiesterase function PDE4B is expressed in the adenoma and adjacent normal colonic epithelium of mammals and silenced in colorectal cancer

por Pleiman, Jennifer K., Irving, Amy A., Wang, Zhishi, Toraason, Erik, Clipson, Linda, Dove, William F., Deming, Dustin A., Newton, Michael A.
Publicado 2018

A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT‐01

por Sahai, Vaibhav, Griffith, Kent A., Beg, Muhammad S., Shaib, Walid L., Mahalingam, Devalingam, Zhen, David B., Deming, Dustin A., Zalupski, Mark M.
Publicado 2022

Autofluorescence Imaging of Treatment Response in Neuroendocrine Tumor Organoids

por Gillette, Amani A., Babiarz, Christopher P., VanDommelen, Ava R., Pasch, Cheri A., Clipson, Linda, Matkowskyj, Kristina A., Deming, Dustin A., Skala, Melissa C.
Publicado 2021

mTOR Inhibition Elicits a Dramatic Response in PI3K-Dependent Colon Cancers

por Deming, Dustin A., Leystra, Alyssa A., Farhoud, Mohammed, Nettekoven, Laura, Clipson, Linda, Albrecht, Dawn, Washington, Mary Kay, Sullivan, Ruth, Weichert, Jamey P., Halberg, Richard B.
Publicado 2013

Colon Cancer Tumorigenesis Initiated by the H1047R Mutant PI3K

por Yueh, Alexander E., Payne, Susan N., Leystra, Alyssa A., Van De Hey, Dana R., Foley, Tyler M., Pasch, Cheri A., Clipson, Linda, Matkowskyj, Kristina A., Deming, Dustin A.
Publicado 2016

Phospholipid Ether Analogs for the Detection of Colorectal Tumors

por Deming, Dustin A., Maher, Molly E., Leystra, Alyssa A., Grudzinski, Joseph P., Clipson, Linda, Albrecht, Dawn M., Washington, Mary Kay, Matkowskyj, Kristina A., Hall, Lance T., Lubner, Sam J., Weichert, Jamey P., Halberg, Richard B.
Publicado 2014

Live cell molecular analysis of primary prostate cancer organoids identifies persistent androgen receptor signaling

por Heninger, Erika, Kosoff, David, Rodems, Tamara S., Sethakorn, Nan, Singh, Anupama, Gungurthi, Harshitha, Carlson, Kristin N., Yang, Bing, Gilsdorf, Cole, Pasch, Cheri A., Deming, Dustin A., Ellis, Leigh, Beebe, David J., Jarrard, David F., Lang, Joshua M.
Publicado 2021

Impact of baseline culture conditions of cancer organoids when determining therapeutic response and tumor heterogeneity

por DeStefanis, Rebecca A., Kratz, Jeremy D., Olson, Autumn M., Sunil, Aishwarya, DeZeeuw, Alyssa K., Gillette, Amani A., Sha, Gioia C., Johnson, Katherine A., Pasch, Cheri A., Clipson, Linda, Skala, Melissa C., Deming, Dustin A.
Publicado 2022

A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer

por Gorbunova, Vera, Beck, J. Thaddeus, Hofheinz, Ralf-Dieter, Garcia-Alfonso, Pilar, Nechaeva, Marina, Cubillo Gracian, Antonio, Mangel, Laszlo, Elez Fernandez, Elena, Deming, Dustin A., Ramanathan, Ramesh K., Torres, Alison H., Sullivan, Danielle, Luo, Yan, Berlin, Jordan D.
Publicado 2018

Correction: A phase 2 randomised study of veliparib plus FOLFIRI±bevacizumab versus placebo plus FOLFIRI±bevacizumab in metastatic colorectal cancer

por Gorbunova, Vera, Beck, J. Thaddeus, Hofheinz, Ralf-Dieter, Garcia-Alfonso, Pilar, Nechaeva, Marina, Gracian, Antonio Cubillo, Mangel, Laszlo, Fernandez, Elena Elez, Deming, Dustin A., Ramanathan, Ramesh K., Torres, Alison H., Sullivan, Danielle, Luo, Yan, Berlin, Jordan D.
Publicado 2019

Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment

por Papadas, Athanasios, Deb, Gauri, Cicala, Alexander, Officer, Adam, Hope, Chelsea, Pagenkopf, Adam, Flietner, Evan, Morrow, Zachary T., Emmerich, Philip, Wiesner, Joshua, Arauz, Garrett, Bansal, Varun, Esbona, Karla, Capitini, Christian M., Matkowskyj, Kristina A., Deming, Dustin A., Politi, Katerina, Abrams, Scott I., Harismendy, Olivier, Asimakopoulos, Fotis
Publicado 2022

Multi‐ancestral origin of intestinal tumors: Impact on growth, progression, and drug efficacy

por Leystra, Alyssa A., Gilsdorf, Brock J., Wisinger, Amanda M., Warda, Elise R., Wiegand, Shanna, Zahm, Christopher D., Matkowskyj, Kristina A., Deming, Dustin A., Khan, Naghma, Rosemarie, Quincy, Sievers, Chelsie K., Schwartz, Alexander R., Albrecht, Dawn M., Clipson, Linda, Mukhtar, Hasan, Newton, Michael A., Halberg, Richard B.
Publicado 2021

Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment

por Sharick, Joe T., Walsh, Christine M., Sprackling, Carley M., Pasch, Cheri A., Pham, Dan L., Esbona, Karla, Choudhary, Alka, Garcia-Valera, Rebeca, Burkard, Mark E., McGregor, Stephanie M., Matkowskyj, Kristina A., Parikh, Alexander A., Meszoely, Ingrid M., Kelley, Mark C., Tsai, Susan, Deming, Dustin A., Skala, Melissa C.
Publicado 2020

Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations

por Moon, Jai-Hee, Hong, Seung-Woo, Kim, Jeong Eun, Shin, Jae-Sik, Kim, Jin-Sun, Jung, Soo-A, Ha, Seung Hee, Lee, Seul, Kim, Joseph, Lee, Dae Hee, Park, Yoon Sun, Kim, Dong Min, Park, Sang-Soo, Hong, Jun Ki, Kim, Do Yeon, Kim, Eun Ho, Jung, Joonyee, Kim, Mi Jin, Kim, Seung-Mi, Deming, Dustin A., Kim, Kyunggon, Kim, Tae Won, Jin, Dong-Hoon
Publicado 2019

ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper

por Dasari, Arvind, Morris, Van K., Allegra, Carmen J., Atreya, Chloe, Benson, Al B., Boland, Patrick, Chung, Ki, Copur, Mehmet S., Corcoran, Ryan B., Deming, Dustin A., Dwyer, Andrea, Diehn, Maximilian, Eng, Cathy, George, Thomas J., Gollub, Marc J., Goodwin, Rachel A., Hamilton, Stanley R., Hechtman, Jaclyn F., Hochster, Howard, Hong, Theodore S., Innocenti, Federico, Iqbal, Atif, Jacobs, Samuel A., Kennecke, Hagen F., Lee, James J., Lieu, Christopher H., Lenz, Heinz-Josef, Lindwasser, O. Wolf, Montagut, Clara, Odisio, Bruno, Ou, Fang-Shu, Porter, Laura, Raghav, Kanwal, Schrag, Deborah, Scott, Aaron J., Shi, Qian, Strickler, John H., Venook, Alan, Yaeger, Rona, Yothers, Greg, You, Y. Nancy, Zell, Jason A., Kopetz, Scott
Publicado 2020